CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net income	$ 3,963	$ 2,352
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	8,496	6,937
Amortization of deferred financing costs charged to interest expense	1,040	904
Stock-based compensation expense	1,573	1,352
Deferred taxes, net	42	0
Changes in operating assets and liabilities:
Accounts receivable	3,662	(1,057)
Other assets	2,187	719
Accounts payable and accrued liabilities	(6,669)	(4,757)
Accrued payroll	(2,038)	8
Other liabilities	(1,955)	404
Net cash provided by operating activities	10,301	6,862
Investing activities
Business acquisition, net of cash acquired	0	(180,711)
Purchase of equipment and improvements	(466)	(463)
Net cash (used in) investing activities	(466)	(181,174)
Financing activities
Proceeds from revolving line of credit	161,555	32,594
Repayment of revolving line of credit	(157,079)	(11,264)
Proceeds from debt obligations	0	168,000
Repayments of debt obligations	(13,063)	(7,125)
Payments of deferred financing costs	0	(7,622)
Proceeds from issuance of common stock upon exercise of options and warrants	261	287
Payment of tax obligations resulting from net exercise of stock options	(1,486)	(649)
Net cash (used in) provided by financing activities	(9,812)	174,221
Net change in cash	23	(91)
Cash - beginning of period	215	228
Cash - end of period	238	137
Supplemental disclosure of cash flow information
Cash paid during the period for interest	7,873	5,714
Cash paid during the period for income taxes	1,798	3,202
Common stock surrendered for the exercise of stock options	$ 2,324	$ 238